Huanyu Chen

2.7k total citations · 1 hit paper
63 papers, 1.8k citations indexed

About

Huanyu Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Computer Vision and Pattern Recognition. According to data from OpenAlex, Huanyu Chen has authored 63 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Computer Vision and Pattern Recognition. Recurrent topics in Huanyu Chen's work include Pancreatic and Hepatic Oncology Research (6 papers), Gastric Cancer Management and Outcomes (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Huanyu Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Gastric Cancer Management and Outcomes (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Huanyu Chen collaborates with scholars based in China, United States and Taiwan. Huanyu Chen's co-authors include Richard Pazdur, Patricia Keegan, Kun He, Gideon M. Blumenthal, Roslyn A. Stone, Robert Justice, Kirsten B. Goldberg, Hong Zhao, Dickran Kazandjian and Mona Patel and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Huanyu Chen

54 papers receiving 1.7k citations

Hit Papers

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatm... 2023 2026 2024 2025 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
    2023 185 citations Zev A. Wainberg, Davide Melisi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huanyu Chen China 18 831 587 382 268 180 63 1.8k
Nan Chen China 28 769 0.9× 1.2k 2.1× 436 1.1× 201 0.8× 284 1.6× 143 2.9k
Belinda E. Clarke Australia 21 424 0.5× 481 0.8× 476 1.2× 293 1.1× 131 0.7× 41 1.6k
Jun Shao China 23 310 0.4× 600 1.0× 302 0.8× 205 0.8× 154 0.9× 70 1.5k
Jiahua Pan China 27 490 0.6× 895 1.5× 671 1.8× 482 1.8× 151 0.8× 112 2.0k
Shintaro Narita Japan 29 644 0.8× 1.3k 2.2× 981 2.6× 605 2.3× 558 3.1× 239 2.9k
Jin Yang China 20 406 0.5× 334 0.6× 411 1.1× 255 1.0× 184 1.0× 68 1.3k
Sven H. Loosen Germany 21 783 0.9× 340 0.6× 446 1.2× 463 1.7× 463 2.6× 88 2.3k
Charles C. Hsu United States 27 1.1k 1.4× 712 1.2× 243 0.6× 232 0.9× 864 4.8× 101 2.3k
Bing Liu China 25 625 0.8× 236 0.4× 946 2.5× 438 1.6× 290 1.6× 136 2.4k
Patricia Guyot France 12 757 0.9× 698 1.2× 261 0.7× 157 0.6× 430 2.4× 43 2.2k

Countries citing papers authored by Huanyu Chen

Since Specialization
Citations

This map shows the geographic impact of Huanyu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huanyu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huanyu Chen more than expected).

Fields of papers citing papers by Huanyu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huanyu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huanyu Chen. The network helps show where Huanyu Chen may publish in the future.

Co-authorship network of co-authors of Huanyu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Huanyu Chen. A scholar is included among the top collaborators of Huanyu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huanyu Chen. Huanyu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Huanyu, Yong Wang, Weisheng Li, & Bin Xiao. (2025). A multi-granularity facial aesthetic evaluation model based on image-text modality. Knowledge-Based Systems. 330. 114502–114502.
3.
Wainberg, Zev A., Davide Melisi, Teresa Macarulla, et al.. (2025). A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3). Future Oncology. 21(7). 765–774.
4.
Guo, Chuanhai, Zhen Liu, Yaqi Pan, et al.. (2025). Early-life undernutrition increases the risk of death from chronic diseases in adulthood: a population-based cohort study. Global Health Research and Policy. 10(1). 28–28.
5.
Weng, Chunhua, et al.. (2025). Mask Augmentation For Tumor Classification In Medical Images. 1–5.
6.
7.
Liu, Yu, Li Zhang, Huanyu Chen, et al.. (2023). Quantitative assessment of renal functions using 68Ga-EDTA dynamic PET imaging in renal injury in mice of different origins. Frontiers in Medicine. 10. 1143473–1143473. 1 indexed citations
8.
Deng, Lixia, et al.. (2023). Three-Dimensional Path Planning of UAV Based on Improved Particle Swarm Optimization. Mathematics. 11(9). 1987–1987. 26 indexed citations
9.
Chen, Huanyu. (2023). A Study of How Technological Innovation Affects China's Economic Development. Advances in Economics Management and Political Sciences. 38(1). 70–78. 1 indexed citations
10.
11.
Wang, Yingxue, et al.. (2022). A Hybrid Model for QoS Prediction based on Improved Conditional Variational Autoencoder. 339–346. 1 indexed citations
12.
Liang, Linlin, Fangfang Liu, Wenlei Yang, et al.. (2022). Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 29(9). 5626–5633. 5 indexed citations
13.
Wang, Jun‐Xian, Guangyan Liu, Kunpeng Zhu, et al.. (2021). Exosomes Protect Against Acute Myocardial Infarction in Rats by Regulating the Renin-Angiotensin System. Stem Cells and Development. 30(12). 622–631. 15 indexed citations
14.
Wang, Hui, Zhen Liu, Chuanhai Guo, et al.. (2021). Health-seeking behavior and barriers to treatment of patients with upper gastrointestinal cancer detected by screening in rural China: real-world evidence from the ESECC trial. The Lancet Regional Health - Western Pacific. 12. 100181–100181. 10 indexed citations
15.
Li, Yuxin, et al.. (2021). Theory and application of artificial intelligence in financial industry. SHILAP Revista de lepidopterología. 1(2). 96–116. 15 indexed citations
16.
Chen, Huanyu, Ping Cai, Yue Feng, et al.. (2021). In vitro and in vivo comparative study of a novel 68Ga-labeled PSMA-targeted inhibitor and 68Ga-PSMA-11. Scientific Reports. 11(1). 19122–19122. 7 indexed citations
17.
Beaver, Julia A., Maitreyee Hazarika, Flora Mulkey, et al.. (2018). Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis. The Lancet Oncology. 19(2). 229–239. 112 indexed citations
18.
Fashoyin‐Aje, Lola A., Martha Donoghue, Huanyu Chen, et al.. (2018). FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD-L1. The Oncologist. 24(1). 103–109. 171 indexed citations
19.
Zhang, Weiping, et al.. (2017). Analytical fuzzy approach to biological data analysis. Saudi Journal of Biological Sciences. 24(3). 563–573. 42 indexed citations
20.
Zhang, Jenny J., Huanyu Chen, Kun He, et al.. (2012). Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis. Therapeutic Innovation & Regulatory Science. 47(2). 167–174. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nan Chen Breakdown of academic impact, for papers by Belinda E. Clarke Breakdown of academic impact, for papers by Jun Shao Breakdown of academic impact, for papers by Jiahua Pan Breakdown of academic impact, for papers by Shintaro Narita Breakdown of academic impact, for papers by Jin Yang Breakdown of academic impact, for papers by Sven H. Loosen Breakdown of academic impact, for papers by Charles C. Hsu Breakdown of academic impact, for papers by Bing Liu Breakdown of academic impact, for papers by Patricia Guyot
Rankless by CCL
2026